Skip to main content

Table 2 Comparison of baseline mean for BMI and serum nesfatin-1, glucose indices, and lipid profile in overweight or obese patients with type 2 diabetes mellitus (T2DM)

From: Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial

Baseline Dependent Variables Caraway
(n = 27)
n(%) or Mean (SD)
Placebo
(n = 25)
n(%) or Mean (SD)
P-value*
BMI (kg/m2) 28.77(3.77) 29.19(3.27) 0.69
WC (cm) 100.32(7.06) 100.35(8.45) 0.94
FBG (mg/dl) 175.38(69.89) 174.04(52.30) 0.92
FBI (μIU/ml) 9.39(6.77) 11.63(7.51) 0.31
HOMA-IR (score) 4.21(3.72) 4.98(3.11) 0.47
QUICKI (score) 0.45(0.01) 0.44(0.01) 0.57
Nesfatin-1 (ng/ml) 4.37(1.65) 5.46(2.14) 0.07
TC (mg/dl) 159.04(36.78) 152.62(48.96) 0.61
TG (mg/dl) 163.34(117.15) 164.23(82.37) 0.97
LDL-C (mg/dl) 81.34(27.61) 83.27(29.58) 0.82
HDL-C (mg/dl) 44.96(11.99) 42.95(7.65) 0.51
  1. *t-test; BMI: body mass index, WC: waist circumference, HOMA-IR: homeostasis model assessment-insulin resistance, QUICKI: quantitative insulin sensitivity check index, FBG: fasting blood glucose, FBI: fasting blood insulin, TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein-cholesterol